About Circular Genomics
Circular Genomics is a private company based in Albuquerque, New Mexico, incorporated in 2021 in Delaware. It has reported $12,639,997 raised in three offerings on Form D since August 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 11, 2024 | Jan 23, 2024 | $8,300,000of $15.0M target | 9 | $922K | EquityRule 506(b) | Form D ↗ |
| Nov 30, 2021 | Dec 9, 2021amended Mar 9, 2023 | $3,149,997of $3.2M target | 7 | $449K | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 5, 2021 | Aug 20, 2021 | $1,190,000of $2.0M target | 7 | $170K | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, three offerings | $12,639,997 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Circular Genomics's Form D filed Jan 23, 2024.
FR
Fortunado Rocca
Director
BD
Blivin David
Director
PS
Paul Sargeant
Executive officer and director
WT
Waneta Tuttle
Director
NM
Nikolaos Mellios
Director
JI
Earlier filings also listed Stephen McKernan (executive officer, last listed Mar 2023), Cathy Petti (director, last listed Mar 2023) and Alexander Hafez (executive officer, director and promoter, last listed Mar 2023).